×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Keymed Biosciences' Stapokibart Gains Priority Review - TipRanks.com
Tipranks
Keymed Biosciences, Inc. (HK:2162) has released an update. Keymed Biosciences Inc. has announced that their Stapokibart injection, a treatment for chronic...
4 days ago
There's Reason For Concern Over Keymed Biosciences Inc.'s (HKG:2162) Massive 28% Price Jump
Simply Wall Street
Despite an already strong run, Keymed Biosciences Inc. ( HKG:2162 ) shares have been powering on, with a gain of 28% in...
2 weeks ago
Pancreatic Cancer Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine ...
Barchart.com
The Pancreatic Cancer Market size was valued approximately USD 1700 million in 2022 and the report offers an in-depth understanding of...
2 weeks ago
AZ enters crowded CLDN18.2 clinical race via Keymed deal
BioCentury
As Astellas nears regulatory submissions for the leading CLDN18.2 program, the clinical pipeline of therapies against the target continues...
14 months ago
Rona, Keymed partner to develop siRNA therapeutics
Pharmaceutical Technology
Rona Therapeutics has entered into a partnership with Keymed Biosciences to discover and develop first-in-class siRNA therapeutics.
12 months ago
Keymed, Lepu Biopharma Enter Global License Agreement with AstraZeneca for CMG901
Contract Pharma
AstraZeneca will be responsible for the research, development, manufacture and commercialization of CMG901 globally.
15 months ago
Astrazeneca gets global rights to Claudin 18.2 ADC from Lepu, Keymed in $1.2B deal
BioWorld MedTech
Indicating its continuing strategy to invest in antibody-drug conjugates (ADCs), Astrazeneca plc obtained exclusive global rights to Claudin...
15 months ago
Keymed raises $378M in Hong Kong debut
BioWorld MedTech
Keymed Biosciences Inc. debuted on the Hong Kong Stock Exchange (HKSE) on July 8, raising HK$2.94 billion (US$378.48 million) in the process...
34 months ago